Characterization of LY231617 protection against hydrogen peroxide toxicity

Journal of Neurochemistry

Volumn 72, Issue 3, 1999, Pages 1154-1160

  Fuson, Kimberly S ^a   Mark, Robert J ^a   Panetta, Jill A ^a   May, Patrick C ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Antioxidant; Ischemia; Neurotoxicity; Oxidative stress

Indexed keywords

2,6 DI TERT BUTYL 4 [(ETHYLAMINO)METHYL]PHENOL; 8 ISOPROSTAGLANDIN F2 ALPHA; GLUTATHIONE; HYDROGEN PEROXIDE; LACTATE DEHYDROGENASE;

ANIMAL TISSUE; ARTICLE; CELL DEGENERATION; CELL PROTECTION; CELL VIABILITY; HIPPOCAMPUS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; TISSUE CULTURE;

ANIMALS; ANTIOXIDANTS; BUTHIONINE SULFOXIMINE; BUTYLATED HYDROXYTOLUENE; CELL SURVIVAL; CULTURE TECHNIQUES; DINOPROST; ENZYME INHIBITORS; F2-ISOPROSTANES; GLUTATHIONE; HIPPOCAMPUS; HYDROGEN PEROXIDE; KINETICS; L-LACTATE DEHYDROGENASE; NEURONS; OXIDANTS; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA;

EID: 0033009602     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0721154.x     Document Type: Article

References (34)

1. Ben-Yoseph O., Boxer P.A., and Ross B. D. (1996) Assessment of the role of glutathione and pentose phosphate pathways in the protection of primary cerebrocortical cultures from oxidative stress. J. Neurochem. 66, 2329-2337.
2. Bridges R. J., Koh J. Y., Hatalski C. G., and Cotman C. W. (1991) Increased excitotoxicity vulnerability of cortical cultures with reduced levels of glutathione. Eur. J. Pharmacol. 192, 199-200.
3. Clark J. B., Fortes M. A., and Brewster D. W. (1996) Modification of an enzymatic glutathione assay for the microtiter plate and the determination of glutathione in rat primary cortical cells. Toxicol. Methods 6, 223-230.
4. Clemens J. A., Saunders R. D., Ho P. P., Phebus L. A., and Panetta J. A. (1993) The antioxidant LY231617 reduces global ischemic neuronal injury in rats. Stroke 24, 716-722.
5. Coyle J. T. and Puttfarcken P. (1993) Oxidative stress, glutamate, and neurodegenerative disorders. Science 262, 689-695.
6. Desagher S., Glowinski J., and Premont J. (1996) Astrocytes protect neurons against hydrogen peroxide toxicity. J. Neurosci. 16, 2553-2562.
7. Desagher S., Glowinski J., and Prémont J. (1997) Pyruvate protects neurons against hydrogen peroxide-induced toxicity. J. Neurosci. 17, 9060-9067.
8. Dexter D. T., Holley A. E., Flitter W. D., Slater T. F., Wells F. R., Daniel S. E., Lees A. J., Jenner P., and Marsden C. D. (1994) Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study. Mov. Disord. 9, 92-97.
9. Esterbauer H., Schaur R. J., and Zollner H. (1991) Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med 11, 81-128.
10. Grasbon-Frodl E. M., Andersson A., and Brundin P. (1996) Lazaroid treatment prevents death of cultured rat embryonic mesencephalic neurons following glutathione depletion. J. Neurochem. 67, 1653-1660.
11. Griffith O. W. (1982) Mechanism of action, metabolism, and toxicity of buthionine sulfoximine and its higher homologs, potent inhibitors of glutathione synthesis. J. Biol. Chem. 257, 13704-13712.
12. Hall E. D., Pazara K. E., and Braughler J. M. (1988) 21-Aminosteroid lipid peroxidation inhibitor U74006F protects against cerebral ischemia in gerbils. Stroke 19, 997-1002.
13. Haraldseth O., Grønås T., and Unsgård G. (1991) Quicker metabolic recovery after forebrain ischemia in rats treated with the antioxidant U74006F. Stroke 22, 1188-1192.
14. Hoyt K. R., Gallagher A. J., Hastings T. G., and Reynolds I. J. (1997) Characterization of hydrogen peroxide toxicity in cultured rat forebrain neurons. Neurochem. Res. 22, 333-340.
15. Inoue N., Yamamoto Y. L., Ito Y., Clemens J. A., Panetta J. A., and Diksic M. (1996) The efficacy of retrograde infusion with LY231617 in a rat middle cerebral artery occlusion model. Can. J. Neurol. Sci. 23, 175-183.
16. ++ in the presence of xylenol orange: comparison with the thiobarbituric acid assay and an iodometric method. Lipids 26, 853-856.
17. ++-oxidation method for detection of lipid peroxide in low density lipoprotein and liposomes. Anal. Biochem. 202, 384-389.
18. Longmire A. W., Swift L. L., Roberts L. J., Awad J. A., Burk R. F., and Morrow J. D. (1994) Effect of oxygen tension on the generation of F2-isoprostanes and malondialdehyde in peroxidizing rat liver microsomes. Biochem. Pharmacol. 47, 1173-1177.
19. May P. C. and Gray P. N. (1985) The mechanism of glulamate-induced degeneration of cultured Huntington's disease and control fibroblasts. J. Neurol. Sci. 70, 101-112.
20. May P. C. and Robison P. M. (1993) Cyclothiazide treatment unmasks AMPA excitotoxicity in rat primary hippocampal cultures. J. Neurochem. 60, 1171-1174.
21. May P. C., Boggs L. N., and Fuson K. S. (1993) Neurotoxicity of human amylin in rat primary hippocampal cultures: similarity to Alzheimer's disease amyloid-β neurotoxicity. J. Neurochem. 61, 2330-2333.
22. May P. C., Panetta J. A., Clemens J, A., Smalstig E. B., Stephenson D., and Fuson K. S. (1996) Induction of sulfated glycoprotein-2 (clusterin) and glial fibrillary acidic protein (GFAP) RNA expression following transient global ischemia is differentially attenuated by LY231617. Mol. Brain Res. 42, 145-148.
23. Meister A. (1988) Glutathione metabolism and its selective modification. J. Biol. Chem. 263, 17205-17208.
24. Morrow J. D. and Roberts L. J. (1996) The isoprostanes: current knowledge and directions for future research. Biochem. Pharmacol. 15, 1-9.
25. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc. Natl. Acad. Sci. USA 87, 9383-9387.
26. Morrow J. D., Frei B., Longmire A. W., Gaziano J. M., Lynch S., Shyr Y., Strauss W., Oates J., and Roberts L. J. (1995) Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. N. Engl. J. Med. 332, 1198-1203.
27. Murphy T. H., Miyamoto M., Sastre A., Schnaar R. L., and Coyle J. T. (1989) Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron 2, 1547-1558.
28. Panetta J. A. and Clemens J. A. (1994) Novel antioxidant therapy for cerebral ischemia-reperfusion injury. Ann. NY Acad. Sci. 723, 239-245.
29. Pradelles P., Grassi J., and Maclouf J. (1990) Enzyme immunoassays of eicosanoids using acetylcholinesterase. Methods Enzymol. 187, 24-34.
30. Shoffner J. M., Brown M. D., Torroni A., Lott M. T., Cabell M. E., Mirra S. S., Beal M. F., Yang C. C., Gearing M., and Salvoandet R. (1993) Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. Genomics 17, 171-184.
31. Subbarao K. V., Richardson J. S., and Ang L. C. (1990) Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro. J. Neurochem. 55, 342-345.
32. Tietze F. (1969) Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal. Biochem. 27, 502-522.
33. Whittemore E. R., Loo D. T., Watt J. A., and Cotman C. W. (1995) A detailed analysis of hydrogen peroxide-induced cell death in primary neuronal culture. Neuroscience 67, 921-932.
34. Yakes F. M. and Van Houten B. (1997) Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc. Natl. Acad. Sci. USA 94, 514-519.